Sage Journals: Discover world-class research

Open access

Review article

First published 2020

Clinical Care of Bone Health in Patients on the Immune Tolerance Induction’s Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia

Zahra Rezaieyazdi, Hassan Mansouritorghabeh

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2024

Rescue immune tolerance induction with a recombinant factor Fc-fused VIII: prospective ReITIrate study of clinical,humoral and cellular immune responses

Christoph Königs, Shannon L. Meeks, Beatrice Nolan [...]

Therapeutic Advances in Hematology

Retricted access

Case report

First published 2021

Providing the conduit for treatment: The impact of vascular access and vein preservation in a 5-year-old child with prenatally diagnosed CRIM-negative Infantile Pompe disease

Matthew Ostroff, Punita Gupta, Daniel Garcia

The Journal of Vascular Access

Open access

Case report

First published 2021

Development and desensitization therapy of high-response factor VIII inhibitors with severe allergic reaction in a moderate hemophilia A patient

Guoqing Liu, Zhenping Chen, Wenman Wu [...]

International Journal of Immunopathology and Pharmacology

Open access

Research article

First published 2021

Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE)

Carmen Escuriola Ettingshausen, Robert F. Sidonio

Therapeutic Advances in Hematology

Open access

Review article

First published 2020

octanate ® : over 20 years of clinical experience in overcoming challenges in haemophilia A treatment

Anna Klukowska, Vladimír Komrska, Vladimír Vdovin [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2021

Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study

Kate Khair, Elizabeth Chalmers, Thuvia Flannery [...]

Therapeutic Advances in Hematology

Search results

Clinical Care of Bone Health in Patients on the Immune Tolerance Induction’s Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia

Rescue immune tolerance induction with a recombinant factor Fc-fused VIII: prospective ReITIrate study of clinical,humoral and cellular immune responses

Providing the conduit for treatment: The impact of vascular access and vein preservation in a 5-year-old child with prenatally diagnosed CRIM-negative Infantile Pompe disease

Development and desensitization therapy of high-response factor VIII inhibitors with severe allergic reaction in a moderate hemophilia A patient

Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE)

octanate ® : over 20 years of clinical experience in overcoming challenges in haemophilia A treatment

Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study